Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Treatment Outcome of Jivi® Prophylaxis on Joint Health in Adult Patients With Hemophilia A

NCT05643560 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05643560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Treatment Outcome of Jivi® Prophylaxis on Joint Health in Adult Patients With Hemophilia A
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
December 29, 2022
Completion date
June 30, 2027
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, prophylaxis of bleeding